Koers Critical Outcome Technologies Inc. Other OTC
Aandelen
CA22675B1031
Biotechnologie & Medisch Onderzoek
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 1,61 mln. 1,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -3,71 mln. | Nettowinst (verlies) 2019 | -2 mln. -1,86 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 40,73K 37,82K | Nettoliquiditeiten 2019 | 24,64K 22,88K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-1,11
x | K/w-verhouding 2019 |
-0,6
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 69,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12-06-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-07-18 | |
John C. Drake
CHM | Chairman | - | 20-02-07 |
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |